series-a
Stage
2018
Founded
1
Investors
About
Saga Diagnostics is a cancer diagnostics company developing and offering highly sensitive liquid biopsy tests for personalized cancer treatment and disease monitoring. They utilize proprietary technologies to detect and quantify cancer-associated DNA mutations in blood samples.
Explore Saga Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.